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Summary
Introduction: Delayed recognition of congenital heart disease (CHD) is not 
infrequent and may have a negative impact on the child’s prognosis. 
A study from our institution published in 2001 showed a rate of late 
diagnosis as high as 10% of all relevant CHD requiring therapy, and this 
rate was equal in cyanotic and acyanotic CHD.
Methods: A study identical to the one 12 years ago was performed with 
prospective evaluation of the time of first diagnosis of CHD during a 3-year 
period ending in June 2011. Only CHD that required surgical or catheter-
based treatment was included. Late diagnosis was defined as diagnosis of 
CHD after discharge from the birth hospital for cyanotic CHD; for acyanotic 
CHD it was defined as first diagnosis at a time when therapy should 
 already have taken place in accordance with recommended standards or if 
immediate treatment was necessary at the time of CHD recognition. In 
 between the two studies came the recommendation of a nationwide neo-
natal pulse oximetry screening, starting in 2006.
Results: A total of 209 patients were included, 41% of these had cyanotic 
and 59% had acyanotic CHD. According to the entry criteria, late diagnosis 
was observed in 21 patients (10% of total population); 6% of cyanotic CHD 
patients (5 of 85) and 13% of acyanotic CHD patients (16 of 124). The two 
most frequently missed CHDs were atrial septal defect and coarctation 
(seven and six patients, respectively). Delayed diagnosis resulted in one 
death (unrecognised interrupted aortic arch in one neonate). Compared 
with the historical study in our referral population the main finding was 
that the total number of late diagnoses remained stable at 10%, with a 
slight decrease only in the rate of late diagnosed cyanotic CHD (from 10 to 
6%) but with a rise in late diagnosed acyanotic CHD from 10 to 13% of all 
patients observed.
Conclusions: After 12 years of referring physician education and the imple-
mentation of a nationwide neonatal pulse oximetry screening, the rate of 
late diagnosis of CHD remained unchanged at 10% of all patients with only 
the rate of cyanotic CHD showing a slight decline.
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ature has dealt with delayed diagnosis of even critical 
CHD [1, 2], and in recent years there was still substan-
tial published evidence of the negative impact on out-
come due to late diagnosis of relevant CHD [3–6].
In our referral population a study was conducted and 
published in 2001, showing the rate of late diagnosis of 
CHD to be 10% without any di­erence between 
 cyanotic and acyanotic CHD in the rate of late detec-
tion [7]. These results led to intensied education of 
 referring physicians (focused clinical workshops for 
the referring paediatricians every 2 years since publi-
cation of the rst study), and in 2006 a nationwide rec-
ommendation for neonatal pulse oximetry was imple-
mented in our country [8]. The current study evaluated 
whether these measures led to a decline in the rate of 
children with CHD being treated late because of missed 
diagnosis.
Methods
The study was identical to that done in our historical 
cohort [7], with a prospective evaluation covering a 
3-year period ending in June 2011. The timing of rst 
 diagnosis of all CHD patients was registered. Only 
 patients with haemodynamically relevant CHD, with 
necessity for either surgical or catheter-based therapy 
were included. Children with CHD but without an indi-
cation for therapy and solely on observation on an out-
patient basis were excluded. Patients admitted for re-
operation or reintervention were excluded, as were 
patients referred from other institutions for treat-
ment.
Patients with late diagnosis in cyanotic CHD were de-
ned as newborns discharged from their birth clinic 
without a diagnosis of heart disease. For acyanotic 
CHD, late diagnosis was dened as rst diagnosis of the 
defect at a time when, according to recommended 
standards [9], treatment should already have taken 
place, or if at the time of diagnosis immediate thera-
peutic action was required.
Echocardiographic screening in foetal life in our 
 country is done by the caring obstetrician twice in 
pregnancy. Pregnant women are referred to a tertiary 
Introduction
For most congenital heart disease (CHD) there is a con-
sensus as to what would be the optimal timing for cor-
rective intervention, allowing for the best possible 
prognosis of the a­ected children. For a long time liter-
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 centre for further evaluation by a specialised foetal 
cardiologist only if primary screening revealed sus-
pect ndings.
Results
During the timespan covered by the evaluation, a total 
of 209 patients with newly diagnosed relevant CHD 
were prospectively included in this study. Eighty-ve 
of the patients had cyanotic CHD and 124 children 
 acyanotic CHD. About half of the patients were diag-
nosed in the early neonatal period (57%) while 51 of the 
patients (24%) were diagnosed at an age later than the 
neo natal period extending up to the age of 15 years. 
 Especially pathologies of the aorta and atrial septal 
 defect had a trend towards higher age at diagnosis of 
CHD. For a contemporary study there was an astonish-
ingly low rate of in-utero diagnosis of only 19% (39 chil-
dren).
Table 1 gives an overview of the individual diagnoses 
encountered and the respective proportion of late 
 diagnosis for each entity.
Late diagnosis of CHD was observed for the group of 
cyanotic patients in 5 of 85 patients (5.9%) and in 16 of 
124 acyanotic patients (12.9%, table 2). For the entire 
study population the rate of late diagnosis was 10%, the 
same level as in our historical patient cohort, where it 
was 9.9%. As shown in table 2, a mild decline in the rate 
of late diagnosis was seen for the cyanotic patients 
(without statistical signicance owing to the low num-
ber of index patients with late diagnosis), as was to be 
expected because of the introduction of the neonatal 
pulse oxymetry screening in Switzerland in 2006. Out 
of the ve infants with late diagnosis in cyanotic CHD, 
two born in private clinics did not have neonatal pulse 
oxymetry screening, two had it correctly done and in 
the last patient it was incorrectly done on the right 
arm instead of the leg.
For the patients with acyanotic CHD there was even a 
mild rise in the rate of late diagnosis from 10% in the 
rst study period to currently 12.9%, and this was espe-
cially due to underdetection of atrial septal defects and 
coarctation. 
A few typical clinical ndings that were not detected 
adequately were seen in the patients who were referred 
late: xed split heart sounds in atrial septal defect were 
clinically present in seven patients. Absent or weak 
Table 1: Spectrum of cardiac malformations and proportion of patients with late diagnosis.
Cardiac diagnosis Total cases Late diagnosis number of patients Age at late diagnosis
Cyanotic  85  5
Tetralogy of Fallot  25  1 4 m
Transposition of
great arteries (simple)
 17  1 4 m
Atrioventricular canal  15
Single ventricle  11  1 6 m
Interrupted aortic arch   5  1 At death
Total anomalous pulmonary venous
connection
  4  1 6 m
Truncus arteriosus   4
Various   4
Acyanotic 124 16
Arial septal defect  25  7 9–16 y
Ventricular septal defect  30  1 4 m
Coarctation  22  7 1 m–10 y
Patent ductus arteriosus   9
Pulmonary stenosis   8
Aortic stenosis   6  1 6 m
Double outlet right ventricle   3
Various  21
m = months; y = years.
Table 2: Proportion of patients with late diagnosis.
Late diagnosis Study period I
1996–1999
Study period II
2008–2011
All patients with CHD 32 / 323 (9.9%) 21 / 209 (10%)
Cyanotic CHD  7 / 72 (9.7%)  5 / 85 (5.9%)
Acyanotic CHD 25 / 251 (10%) 16 / 124 (12.9%)
Comparison between the current and the historical study.
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femoral pulses were the leading clinical sign in seven 
patients but were not detected until late diagnosis was 
made. Clearly present increased precordial pulsation 
on palpation of the thorax was noticed in four infants 
but was not reported before.
Only a few patients had clinical consequences as a re-
sult of late referral: there was one mortality due to late 
diagnosis of interrupted aortic arch with intractable 
cardiogenic shock at referral to the intensive care unit 
at 7 days of life. Two teenagers with an atrial septal de-
fect (13 and 15 years old at referral and at device closure 
with an Amplatzer) did not normalise the size of their 
right heart structures during a 2-year follow-up.
Discussion
The main nding of this study was that in a contempo-
rary cohort of children with newly diagnosed relevant 
CHD there was still a signicant proportion of patients 
with late referral and late diagnosis of CHD. In compar-
ison with an identical historical study published in 
2001 [7], the overall rate of late diagnosis remained sta-
ble at 10% of patients with relevant CHD. The only dif-
ference was that there was a mild (although not signi-
cant) decline in late diagnosis of cyanotic CHD, whereas 
a slightly larger proportion of patients with acyanotic 
CHD were diagnosed late. The rise in the number of 
acyanotic patients diagnosed late was largely due to 
patients with coarctation and atrial septal defect. Late 
diagnosis of atrial septal defect even in the adult age is 
a constant nding in large populations undergoing 
echocardiographic studies [10] and thus not surprising. 
The mild decline in late referrals of  cyanotic CHD pa-
tients is attributable to neonatal pulse oximetry 
screening (on the rst day of life),  although the re-
maining few patients not detected by screening make 
clear that in addition to pulse oximetry screening, a 
clinical examination still plays an important part as 
outlined in the recommendations accompanying the 
original screening guidelines [8].
The aim of a timely diagnosis of CHD is to minimise 
morbidity and mortality that may be associated with 
late referral [3, 5] and which may be relevant to the 
child’s prognosis. Morbidity was low in the current 
study, but the case of a newborn who died because of a 
missed interruption of the aortic arch is alarming, this 
condition being amenable to surgical treatment with 
good long-term results.
Another asthonishing result of the current evaluation 
is the very low rate of antenatal echocardiographic di-
agnosis of relevant CHD, the detection rate of 19% 
 being clearly below target standards in the current era 
[11], given the proven benet of antenatal diagnosis in 
the management of critical CHD [12].
In summary, because during the past decade the rate 
of late detection of CHD did not show any decline, 
 e­orts to improve this performance have to continue 
on all levels, a higher detection rate of critical CHD 
 already in  utero as well as better recognition neona-
tally must be aimed for. Clinical recognition of atrial 
septal defects and coarctation must also be improved 
in order not to compromise the individual patient’s 
prognosis.
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